BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 32609451)

  • 1. Eosinophilic dermatosis of hematologic malignancy: a case report.
    Almeida FT; Caldas R; Rodrigues AP; Ferreira O; Brito C
    Dermatol Online J; 2020 Mar; 26(3):. PubMed ID: 32609451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eosinophilic Dermatosis of Hematologic Malignancy.
    Lucas-Truyols S; Rodrigo-Nicolás B; Lloret-Ruiz C; Quecedo-Estébanez E
    Actas Dermosifiliogr; 2017; 108(6):e39-e44. PubMed ID: 28342533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of eosinophilic dermatosis of hematologic malignancy in a patient with multiple myeloma.
    Two AM; Li C; Hata T
    Dermatol Online J; 2014 Jan; 20(1):21256. PubMed ID: 24456959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eosinophilic dermatosis of hematologic malignancy.
    Martires K; Callahan S; Terushkin V; Brinster N; Leger M; Soter NA
    Dermatol Online J; 2016 Dec; 22(12):. PubMed ID: 28329554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eosinophilic fasciitis as a paraneoplastic syndrome, a case report and review of the literature.
    Haddad H; Sundaram S; Magro C; Gergis U
    Hematol Oncol Stem Cell Ther; 2014 Jun; 7(2):90-2. PubMed ID: 24525268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What's in a name? a new nomenclature has been proposed For eosinophilic dermatosis of hematologic malignancy (EDHM): hematologic-related malignancy-induced eosinophilic dermatosis (He Remained).
    Cohen PR
    Dermatol Online J; 2020 Jun; 26(6):. PubMed ID: 32815699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lenalidomide in the management of eosinophilic dermatosis of hematological malignancy.
    Sato-Sano M; Teixeira SP; Vargas JC; Baiocchi OCCG; Enokihara MMSES; Gomes EE; Batista MD
    J Dermatol; 2019 Jul; 46(7):618-621. PubMed ID: 31144726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flame figures associated with eosinophilic dermatosis of hematologic malignancy: is it possible to distinguish the condition from eosinophilic cellulitis in patients with hematoproliferative disease?
    Qiao J; Sun CE; Zhu W; Zhu D; Fang H
    Int J Clin Exp Pathol; 2013; 6(8):1683-7. PubMed ID: 23923089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eosinophilic dermatosis of hematologic malignancy: Correlation of molecular characteristics of skin lesions and extracutaneous manifestations of hematologic malignancy.
    Meiss F; Technau-Hafsi K; Kern JS; May AM
    J Cutan Pathol; 2019 Mar; 46(3):175-181. PubMed ID: 30411384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eosinophilic Dermatosis of Myeloproliferative Disease in a Young Adult With Diffuse Large B-Cell Lymphoma.
    Jencks A; Kiavash K; Daveluy S; Thompson AD
    Am J Dermatopathol; 2019 Apr; 41(4):303-308. PubMed ID: 30252694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eosinophilic dermatosis of hematologic malignancy.
    Farber MJ; La Forgia S; Sahu J; Lee JB
    J Cutan Pathol; 2012 Jul; 39(7):690-5. PubMed ID: 22612903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eosinophilic dermatosis of hematologic malignancy in patients with chronic lymphocytic leukemia/non-Hodgkin's B lymphoma: a single center prospective clinico-pathological study.
    Michelerio A; Tomasini C; Fiandrino G; De Amici M; Varettoni M; Defrancesco I; Cavalloni C; Brazzelli V; Derlino F; Paulli M; Arcaini L; Vassallo C
    Front Med (Lausanne); 2023; 10():1231003. PubMed ID: 37614953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eosinophilic Dermatoses: Recognition and Management.
    Marzano AV; Genovese G
    Am J Clin Dermatol; 2020 Aug; 21(4):525-539. PubMed ID: 32394361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Case of Eosinophilic Dermatosis of Hematologic Malignancy Treated With Narrow-Band Ultraviolet B (NBUVB).
    Pan S; Bicknell L
    Cureus; 2023 Mar; 15(3):e35734. PubMed ID: 37016657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eosinophilic dermatosis of myeloproliferative disease: characterization of a unique eruption in patients with hematologic disorders.
    Byrd JA; Scherschun L; Chaffins ML; Fivenson DP
    Arch Dermatol; 2001 Oct; 137(10):1378-80. PubMed ID: 11594874
    [No Abstract]   [Full Text] [Related]  

  • 16. Effective treatment of eosinophilic dermatosis of haematological malignancy with montelukast.
    Besley L; Wheller L; Mortimore R
    Australas J Dermatol; 2021 Feb; 62(1):e123-e124. PubMed ID: 32671823
    [No Abstract]   [Full Text] [Related]  

  • 17. Eosinophilic dermatitis of hematologic malignancy.
    Penn L; Ahern I; Mir A; Meehan SA
    Dermatol Online J; 2015 Dec; 21(12):. PubMed ID: 26990335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eosinophilic dermatosis of hematologic malignancy responding to dupilumab in a patient with chronic lymphocytic leukemia.
    Jin A; Pousti BT; Savage KT; Mollanazar NK; Lee JB; Hsu S
    JAAD Case Rep; 2019 Sep; 5(9):815-817. PubMed ID: 31508473
    [No Abstract]   [Full Text] [Related]  

  • 19. Eosinophilic dermatosis of haematological malignancy.
    Jayasekera PS; Bakshi A; Al-Sharqi A
    Clin Exp Dermatol; 2016 Aug; 41(6):692-5. PubMed ID: 27378400
    [No Abstract]   [Full Text] [Related]  

  • 20. Eosinophilic dermatosis of hematologic malignancy: Reality bites.
    Heymann WR
    J Am Acad Dermatol; 2019 Jul; 81(1):74-75. PubMed ID: 31059721
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.